Animal Health in 2005 and Beyond

Animal Health in 2005 and Beyond

Comprehensive forecasting of market, company, strategic and regulatory developments within the animal health industry over the next 5-10 years

This report provides an in-depth analysis of how key issues facing the animal health industry are expected to develop over the next decade. It includes market projections and outlines likely technological advances in animal health, allowing you to build a complete picture of tomorrow's market.

Animal Health in 2005 and Beyond offers you access to a wide range of expert opinions on how the market is set to change. Each chapter has been written by a recognised industry expert specialising in that particular field to provide an authoritative viewpoint, enabling you to:

* analyse likely company, market and technological developments
* investigate prospective areas of research
* examine potential regulatory and legislative changes

The report addresses the future of seven key areas within the animal health industry:
* research
* immunology
* genetics
* generics
* product registration and availability
* market structure
* company prospects

This report covers every aspect of the animal health industry, enabling you to examine future trends and discover which developing technologies are becoming key to continued market success.

PUBLISHED: MAY 1998
REF: SR172E
PAGES: 126
PRICE: £695/$1,460/¥167,000

CONTENTS LIST OF TABLES
LIST OF FIGURES
INTRODUCTION
Pointers to the future
Animal health markets
Product sector performances
Company prospects and competitive requirements
Research in the 21st Century
Regulation and product availability
Animal health in 2005 and beyond

CHAPTER 1 THE RESEARCH CLIMATE FOR ANIMAL HEALTH
1.1 Introduction
1.2 Forces shaping tomorrow's R&D environment
1.2.1 Market fragmentation and niche characteristics
1.2.2 Key driving forces of the animal health industry
1.3 Crystal-ball gazing for the 21st Century
1.3.1 Key assumptions
1.3.2 Product predictions for 2005
1.4 Conclusions

CHAPTER 2 DEVELOPMENTS IN IMMUNOLOGICAL PRODUCTS AND TECHNOLOGY
2.1 Introduction
2.2 Developments in vaccine technology
2.2.1 Active ingredients
2.2.2 Future developments in vaccine formulation
2.2.3 Future developments in vaccine administration
2.2.4 Concluding remarks
2.3 New disease and parasite targets
2.3.1 Vaccines against endoparasites
2.3.2 Vaccines against ectoparasites
2.3.3 Vaccines against zoonotic diseases
2.4 Application of immunological approaches to new areas
2.5 Future leaders of technological advance
2.6 Immunologicals and total animal health product sales
2.7 Future regulation of immunological products
2.8 Conclusions
2.8.1 Vaccines
2.8.2 Novel immunologicals

CHAPTER 3 GENETICS AND ANIMAL HEALTH
3.1 Introduction
3.2 Genetic manipulation of the pathogen
3.2.1 Recombinant vector vaccines
3.2.2 DNA vaccination
3.2.3 Maximising host responses
3.3 Animal breeding
3.3.1 Exploiting disease resistance genes
3.3.2 Transgenics
3.3.3 Cloning
3.3.4 Exploiting anti-pathogenic mechanisms
3.4 Conclusions

CHAPTER 4 PRODUCT REGULATION AND AVAILABILITY: A CASE STUDY OF THE EU REGION
4.1 Introduction
4.1.1 Development of the European regulatory framework
4.1.2 Principles of good regulation
4.2 The EU product reviews
4.3 Maximum Residue Limits (MRLs)
4.3.1 The MRL concept
4.3.2 JECFA and MRLs
4.3.3 MRLs in the EU
4.3.4 Clinical trials and MRLs
4.4 The hormones legislation
4.5 Antibiotics and antimicrobials
4.5.1 Microbiological end-points
4.5.2 Antimicrobial resistance
4.6 Transmissible spongiform encephalopathies (TSEs)
4.7 Ecotoxicity
4.8 The VICH initiative
4.9 Conclusions

CHAPTER 5 GENERICS: A CASE STUDY OF THE AVERMECTINS MARKET
5.1 Introduction
5.2 Early generic markets
5.2.1 South America
5.2.2 Australasia
5.2.3 South Africa
5.3 Regulatory considerations
5.3.1 The US
5.3.2 Europe
5.4 Marketing strategies
5.4.1 Pricing
5.4.2 Distribution and branding
5.5 Future market developments
5.5.1 Southern Hemisphere markets
5.5.2 Northern Hemisphere markets
5.6 Distribution
5.7 The resistance issue
5.8 Patent expiry dates and future market opportunities

CHAPTER 6 ANIMAL HEALTH MARKETS IN 2005 AND BEYOND
6.1 Introduction
6.2 Factors likely to affect future market growth
6.2.1 Livestock production
6.2.2 Consumer attitudes
6.2.3 Livestock producers
6.2.4 Manufacturers
6.2.5 Species sectors
6.2.6 Research and development
6.2.7 The regulatory framework
6.3 Prospective growth sectors: products
6.3.1 Biologicals
6.3.2 Diagnostics
6.3.3 Major pharmaceuticals
6.3.4 Niche pharmaceuticals
6.3.5 Niche species
6.4 Prospective growth sectors: regional markets
6.4.1 Latin America
6.4.2 Australasia
6.4.3 Asia
6.5 Prospective growth sectors: species
6.5.1 Cattle
6.5.2 Pigs and poultry
6.5.3 Companion animals
6.6 Conclusions
6.6.1 Market size
6.6.2 Product sectors
6.6.3 Regional market growth
6.6.4 Species market growth
6.7 Factors affecting market development beyond 2005

CHAPTER 7 COMPANY PROSPECTS AND COMPETITIVE REQUIREMENTS
7.1 Introduction
7.1.1 Current market situation
7.1.2 Recent merger and acquisition activity
7.1.3 Species niches
7.1.4 Research specialists
7.2 Factors affecting company prospects
7.2.1 Regional market growth
7.2.2 Parent company activities and requirements
7.2.3 Portfolios
7.3 Competitive requirements
7.3.1 Parent company commitment
7.3.2 Global marketing reach or niche strength
7.3.3 Direction, focus and management quality
7.3.4 Research and development
7.3.5 Regulatory expertise
7.3.6 IT capabilities
7.4 Prospective winners and losers
7.4.1 The major players
7.4.2 Promising prospects
7.5 Conclusions

LIST OF TABLES
Table 1.1 Animal health product revenue ranges
Table 1.2 Animal health revenue leaders
Table 1.3 Human medicine revenue leaders
Table 1.4 Parent company commitment to animal health
Table 1.5 Product development trends to 2005
Table 1.6 Companion animal products in 2005 - changes from 1998 ethical products
Table 1.7 Food animal products in 2005 - changes from 1998 products for all trade channels world-wide
Table 2.1 Currently available vector vaccines
Table 2.2 Currently available marker vaccines
Table 2.3 Currently available sub-unit vaccines
Table 2.4 Immunological product categories and development prospects
Table 3.1 Disease resistance genes
Table 5.1 Ivermectin patent expiry dates
Table 6.1 World animal populations
Table 6.2 Major animal health markets
Table 6.3 World market shares by product sector
Table 6.4 Forecast changes in market structure by product sector, 1997-2005
Table 7.1 Animal health company sales ($ million, 1997)
Table 7.2 Animal health company contributions to parent sales

LIST OF FIGURES
Figure 1.1 Animal health industry market segments: product categories & differentiation
Figure 6.1 World animal health market share by region
Figure 6.2 Forecast animal health market structure by product category